Evidence map›Paper›PMID 19383550›Full record

ReviewProstaglandins & other lipid mediators2009

G2A and LPC: regulatory functions in immunity.

Janusz H Kabarowski

Abstract readReview
In one paragraph

Review in Prostaglandins & other lipid mediators, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 134 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Hypoxia Modulates Membrane Mechanics in Pancreatic Cancer.The Journal of membrane biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Janusz H KabarowskiDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294-2170, USA. janusz@uab.edu
University of Alabama at Birmingham · US

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
The role of the G2A receptor in AtherosclerosisR01HL088642 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KABAROWSKI, JANUSZ H · 2007 to 2011
$1.8M
NHLBI NIH HHS R01 HL088642NIAMS NIH HHS P30 AR048311
6 · The paper itself

Abstract

The G2A receptor was originally identified by virtue of its transcriptional induction in murine B lymphoid cells in response to oncogenic transformation and treatment with various DNA-damaging agents. While preliminary characterization of cellular responses to G2A overexpression in fibroblastic cell lines suggested that this receptor may negatively regulate cell growth under conditions of proliferative and genotoxic stress, subsequent studies driven by the discovery of lysophosphatidylcholine (LPC) as a regulator of G2A signaling in immunoregulatory cells point to an important role for this receptor in innate and adaptive immunity.

Indexed as

ImmunityImmunity, InnateAnimalsApoptosisAtherosclerosisAutoimmunityCell Cycle ProteinsChemotaxisGene Expression RegulationHumansLeukocytesLigandsLysophosphatidylcholinesMacrophagesReceptors, G-Protein-CoupledSepsisCell Cycle ProteinsG2A receptorLigandsLysophosphatidylcholinesReceptors, G-Protein-Coupled

Identifiers

PMID19383550
PMCPMC2740801
OpenAlexW2086833302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.